Health & Fitness
Health and Fitness
Health and Fitness 
Fri, February 11, 2011
Thu, February 10, 2011
Imaging Diagnostic Systems Installs CT laser Mammography system in Indonesia
FORT LAUDERDALE, Fla.--([ BUSINESS WIRE ])--Imaging Diagnostic Systems, Inc., (OTCBB:[ IMDS.OB ]), a pioneer in laser breast imaging, announced today that it has completed installation and training for its (CTLM®) in Jakarta, Indonesia at the Hang Lekiu Medical Center.
"We are thrilled to have the CTLM system in Jakarta, the largest city in Indonesia. The Hang Lekiu Medical Center and the new arrival of the CTLM system has generated tremendous interest in this exciting new breast imaging technology."
Hang Lekiu Medical Center provides multi-disciplined medical care in a patient friendly environment. This progressive medical center offers a variety of services through a network of specialists. On February 11th, 2011, Hang Lekiu Medical Center is presenting the CTLM system to Indonesia's Health Minister Endang Rahayu Sedyaningsih, local officials and various news organizations.
aWe are thrilled to have the CTLM system in Jakarta, the largest city in Indonesia. The Hang Lekiu Medical Center and the new arrival of the CTLM system has generated tremendous interest in this exciting new breast imaging technology. a commented Linda Grable/CEO for IDSI.
The CTLM system has received international certifications and licenses from the European CE mark, CMDCAS Canadian Health screening, China SFDA, India, UL, and ISO 13485.
About Imaging Diagnostic Systems, Inc.
Imaging Diagnostic Systems, Inc. has developed a revolutionary breast imaging device to aid in the detection and management of breast cancer. The CTLM® system is a breast imaging system that utilizes patented laser technology and computer algorithms to create 3-D images of the breast. The procedure is non-invasive, painless, and does not expose the patient to ionizing radiation or painful breast compression. CT Laser Mammography (CTLM®) is designed to be used in conjunction with mammography. It reveals information about blood distribution in the breast and visualizes the process of angiogenesis; which is a strong indication of tumor growth.
For more information, visit our website: [ www.imds.com ]
As contemplated by the provisions of the Safe Harbor section of the Private Securities Litigation Reform Act of 1995, this news release may contain forward-looking statements pertaining to future, anticipated, or projected plans, performances and developments, as well as other statements relating to future operations. All such forward-looking statements are necessarily only estimates or predictions of future results or events and there can be no assurance that actual results or events will not materially differ from expectations. Further information on potential factors that could affect Imaging Diagnostic Systems, Inc., is included in the Companya™s filings with the Securities and Exchange Commission. We expressly disclaim any intent or obligation to update any forward-looking statements.